NATALIE SPILLER: Open Payments
NPI 1942550272 · HERRIN, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,263 in 69 payments from 14 companies in 2025. Trend: 2023 $1,605 · 2024 $2,159 · 2025 $1,263
Food & beverage: $1,191Education: $72
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 19 | $255 |
| ABBVIE INC. | 11 | $235 |
| Galderma Laboratories, L.P. | 14 | $220 |
| Janssen Biotech, Inc. | 4 | $130 |
| Organon LLC | 7 | $114 |
| Novartis Pharmaceuticals Corporation | 3 | $74 |
| GENZYME CORPORATION | 3 | $63 |
| Incyte Corporation | 2 | $43 |
| Solta Medical, a division of Bausch Health US, LLC | 1 | $30 |
| Lilly USA, LLC | 1 | $24 |
Products named: OTEZLA, NEMLUVIO, TREMFYA, RINVOQ, SKYRIZI, OPZELURA, VTAMA, DUPIXENT.
Industry payments across IL — which companies pay providers there.
